<DOC>
	<DOCNO>NCT00643318</DOCNO>
	<brief_summary>The purpose study assess short long-term outcome CyberKnife stereotactic radiosurgery early stage non-small cell lung cancer ( NSCLC ) patient medically inoperable .</brief_summary>
	<brief_title>CyberKnife Radiosurgical Treatment Inoperable Early Stage Non-Small Cell Lung Cancer</brief_title>
	<detailed_description>The objective clinical evaluation ass outcomes patient undergo stereotactic radiosurgery ( SRS ) treat primary early stage non-small cell lung cancer ( NSCLC ) patient ( comprise two cohort , peripheral central ) candidate surgical resection high operative risk . In particular , effect CyberKnife SRS clinical response rate , local control , progression-free survival , overall survival , dyspnea QOL ( U.S. sit ) , radiological finding two year treatment evaluate .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>1 . Patient must age 18 year 2 . Pulmonary nodule maximum diameter ≤ 5 cm 3 . Histological confirmation primary NSCLC 4 . The following stage NSCLC patient eligible : Stage I : T1 N0 M0 T2 N0 M0 ( Tumor size ≤ 5 cm ) Stage II : T3 N0 M0 ( Chest wall invasion , Tumor size ≤ 5 cm ) 5 . ECOG/Zubrod status 0 , 1 2 6 . Thoracic surgery consultation obtain Board Certified Thoracic surgeon collaboration radiation oncologist determine patient surgical candidate . 7 . In order consider medically inoperable , patient must meet least one major criterion minimum 2 minor criterion describe : MAJOR CRITERIA : 1 . FEV1 &lt; 50 % predict postoperative FEV1 &lt; 40 % 2 . DLCO &lt; 50 % predict postoperative DLCO &lt; 40 % 3 . Exercise induce maximal exercise oxygen consumption M VO2 &lt; 15 mL/kg/min 4 . Highrisk cardiac disease : Any one following : Poor leave ventricular function ( define ejection fraction &lt; =20 % ) Unstable coronary syndrome ( unstable angina severe angina Canadian class III IV ) . Severe valvular disease ( critical valvular stenosis ) , Recent myocardial infarction ( &lt; 1 month ) , Significant arrhythmia define one following : Highgrade AV block , Symptomatic ventricular arrhythmia presence underlie heart disease , Supraventricular arrhythmia uncontrolled ventricular rate MINOR CRITERIA : 1 . Age &gt; 75 2 . Pulmonary hypertension ( define pulmonary artery systolic pressure great 40 mm Hg ) 3 . Oxygen requirement ( use Medicare criterion home oxygen requirement [ i.e. , room air oxygen saturation 88 % less ] ) 4 . Resting exercise arterial pO2 ≤ 55 mm Hg OR SpO2 ≤ 88 % . 5. pCO2 &gt; 45 mm Hg 6 . Congestive heart failure ( three follow must document : dyspnea , peripheral edema , chest xray interstitial edema cardiomegaly , rale , congestion ) 7 . Moderately depressed leave ventricular function ( define ejection fraction 2140 % le ) 8 . Severe cerebral ( CVA recent TIA ) severe peripheral vascular disease 9 . Diabetes Mellitus severe organ damage ESRD , Blindness , Vascular disease . 10 . Severe end organ damage cause result ESRD , cirrhosis liver vascular disease 11 . FEV1 51 % 60 % predict postoperative FEV1 4150 % 12 . DLCO 5160 % predict postoperative DLCO 4150 % 13 . Modified Medical Research Council Dyspnea Scale ≥ grade 3 8 . Females childbearing age must use reliable form birth control . 9 . The patient must PETCT scan within 8 week registration . 10 . The patient must provide sign dated write informed consent PRIOR registration prior undergoing studyrelated procedure . 11 . The patient must provide write authorization allow use disclosure protect health information . 1 . Excluding primary cancer target treatment , patient prior history cancer ( within last 5 year ) concurrent cancer basal cell squamous skin cancer . 2 . Visible endobronchial lesion see trachea , carina , major bronchus , lobar segmental bronchus bronchoscopy microscopic disease detect trachea , carina , major bronchus , lobar segmental bronchus . 3 . The patient 's weight exceed tolerance institution 's imaging CyberKnife platform/couch . 4 . The patient receive thoracic radiation therapy field plan treatment area past . 5 . The patient complete chemotherapy within less 30 day treatment . 6 . T2 : Tumor size &gt; 5 cm , T3 tumor ( except T3 virtue chest wall invasion ≤ 5 cm ) , T4 tumor . Presence N1 , N2 N3 disease per previously describe criterion would exclude . 7 . Pancoast tumor would exclude . 8 . Current distant metastatic disease ( M1 ) ( preferably biopsy proven ) . 9 . The patient female childbearing potential refuse take pregnancy test prior treatment . 10 . The patient pregnant female nursing infant . 11 . The patient plan undergoing systemic therapy within 2 week last fraction radiation 12 . The patient active systemic pulmonary infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>lung cancer</keyword>
	<keyword>lung tumor</keyword>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>NSCLC</keyword>
	<keyword>CyberKnife</keyword>
	<keyword>radiosurgery</keyword>
	<keyword>lung surgery</keyword>
</DOC>